Survival and quality of life in HIV-positive patients treated with a polyantigenic immunomodulator.

A polyantigenic immunomodulator (PAI), previously known as polyantigenic vaccine, which consists of a mixture of antigens of inactivated bacteria with antigens of influenza virus in a peanut-oil-arlacel-A-aluminium monoesterate emulsion, increased tumor resistance and induced tumor regression in tumor bearing mice. This report presents clinical and laboratory data that demonstrate the effect of PAI in long term prolongation of disease free state in HIV positive patients. A total of 40 patients, 35 males and 5 females, with a mean age of 41.1 +/- 10.5 years, ranging from 28 to 68 years, HIV positive by (ELISA and Western Blot), with no restriction on the CD4 + T lymphocytes counts, were included in this open study. The PAI regimen was one subcutaneous injection per week for patients with < 400 CD4 + lymphocytes and one monthly injection for patients with CD4 + count > 400. All patients were monitored at different intervals for lymphocyte counts, clinical condition and treatment toxicity. After a follow up of eight years 81% of the patients were alive and 47% were free of disease. In patients without AIDS, the weight was 153.9 +/- 28 pounds pre-PAI and 164.6 +/- 27 (P = 1.2 x 10(-4); the CD4 + lymphocyte count was 795 +/- 421 pre-PAI and 585 +/- 279 post PAI (P = 0.08). In patients alive with AIDS, the weight was 159.5 +/- 32 pre-PAI and 163.9 +/- 32 pounds post-PAI (P = 0.8); the CD4 + lymphocyte counts was 491 +/- 255 pre-PAI and 298 +/- 142 post-PAI (P = 0.08); and five AIDS-related infections occurred in five patients. In patients who died the weight was 157.7 +/- 23 pre and 146.8 +/- 30 post (P = 0.10); and the CD4 count was 340.7 +/- 149 pre and 103.4 +/- 88 post (P = 0.0057). All died with infection. No toxicity with the use of PAI was reported. PAI improves disease free survival and quality of life in HIV + patients.

Survival and quality of life in HIV-positive patients treated with a polyantigenic immunomodulator

A polyantigenic immunomodulator (PAI), previously known as polyantigenic vaccine, which consists of a mixture of antigens of inactivated bacteria with antigens of influenza virus in a peanut-oil-arlacel-A-aluminium monoesterate emulsion, increased tumor resistance and induced tumor regression in tumor bearing mice. This report presents clinical and laboratory data that demonstrate the effect of PAI in long term prolongation of disease free state in HIV positive patients. A total of 40 patients, 35 males and 5 females, with a mean age of 41.1 +/- 10.5 years, ranging from 28 to 68 years, HIV positive by (ELISA and Western Blot), with no restriction on the CD4 + T lymphocytes counts, were included in this open study. The PAI regimen was one subcutaneous injection per week for patients with < 400 CD4 + lymphocytes and one monthly injection for patients with CD4 + count > 400. All patients were monitored at different intervals for lymphocyte counts, clinical condition and treatment toxicity. After a follow up of eight years 81 percent of the patients were alive and 47 percent were free of disease. In patients without AIDS, the weight was 153.9 +/- 28 pounds pre-PAI and 164.6 +/- 27 (P = 1.2 x 10(-4); the CD4 + lymphocyte count was 795 +/- 421 pre-PAI and 585 +/- 279 post PAI (P = 0.08). In patients alive with AIDS, the weight was 159.5 +/- 32 pre-PAI and 163.9 +/- 32 pounds post-PAI (P = 0.8); the CD4 + lymphocyte counts was 491 +/- 255 pre-PAI and 298 +/- 142 post-PAI (P = 0.08); and five AIDS-related infections occurred in five patients. In patients who died the weight was 157.7 +/- 23 pre and 146.8 +/- 30 post (P = 0.10); and the CD4 count was 340.7 +/- 149 pre and 103.4 +/- 88 post (P = 0.0057). All died with infection. No toxicity with the use of PAI was reported. PAI improves disease free survival and quality of life in HIV + patients

Controlled release of theophylline from inert matrices: effect of channeling material on release rate.

Sustained release theophylline tablets containing stearic acid wax and lactose fast flo as chanelling agent were prepared and evaluated. The fusion technique was used for dispersing the drug in the different levels of stearic acid. The release rate of theophylline from the prepared tablets increased with the increase of the level of the channeling material in the formula. The drug release from tablets containing high level of wax (30 and 60%) and low level of channeling material (59% and 29%) followed the diffusion controlled model for inert porous matrix. The drug release increased significantly with the increase of lactose fast flow level in the formula. After 2 hours of testing dissolution, the tablets start to erode and the mechanism of drug release deviate from the diffusion controlled model. The mechanism of drug release was dependent on the level of the channeling material in the matrix.

[Development and usefulness of a longitudinal study on aspirations and experiences of the students at the health-related professions college]. / Desarrollo y utilidad de un estudio longitudinal sobre aspiraciones y experiencias de los estudiantes del colegio de profesiones relacionadas con la salud.

Longitudinal student track studies are based in the growing need of the institutions of higher education for an integrated student information system that will facilitate decision making in institutional development. To this end, information regarding students from the "Colegio de Profesiones Relacionadas con la Salud (CPRS)" of the Medical Sciences Campus, at different stages in their academic life, has been collected. This will enable us to know about their experiences and their needs. Students admitted to the CPRS during the academic year of 1987-88 and thereafter were asked upon admittance to fill-out a questionnaire and another one upon graduation. The information obtained suggested the effectiveness of the institution in helping the student to achieve their academic, professional and personal aspirations. This was not so regarding their sociocultural goals. The implications of these findings concerning the different academic management stages are discussed herein.

Proyecto de un modelo de detección y tratamiento precoz en casos mentales / Proyect of a model for early detection and treatment in mental cases

En los últimos años las ciudades han experimentado un incremento rápido y desordenado de su población, lo cual ha demostrado en diferentes estudios que esto afecta en diferentes formas la salud de los individuos y la familia, creando entre ellas causas de morbilidad, un aumento de la morbilidad mental, la cual se puede manifestar bajo formas muy diversas como problemas físicos, dilincuencia, suicidios, drogadicción y afecciones mentales no psicóticos. A esta situación hay que añadir el sufrimiento de los pacientes y la merma del rendimiento económico de la unidad familiar del propio enfermo y de la comunidad en general y al mismo tiempo representan una proporcion importante del total de enfermedades atendidas en los servicios sanitarios curativos y ocurre frecuentemente que ni los médicos, ni los planificadores sanitarios se percatan de este hecho lo cual tiende a agradar el problemas. Por eso nos preguntamos como afectan los programas de atención en salud mental urbano la demanda de asistencia de Salud Mental en el Estado Yaracuy?